395 results
8-K
EX-99.2
SEEL
Seelos Therapeutics Inc
19 Mar 24
Other Events
4:05pm
Securities Litigation Reform Act of 1995. These forward - looking statements include, but are not limited to, statements r egarding the intent, belief
8-K
EX-99.1
SEEL
Seelos Therapeutics Inc
19 Mar 24
Other Events
4:05pm
harbor provided by the Private Securities Litigation Reform Act of 1995. These statements include, among others, those regarding the Phase 2/3 study of SLS
8-K
SEEL
Seelos Therapeutics Inc
19 Mar 24
Other Events
4:05pm
by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in the Press Release
8-K
EX-10.2
SEEL
Seelos Therapeutics Inc
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending any litigation, proceeding
8-K
EX-10.1
n6xm4gmz3xiqde
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
424B5
u0uowdu1hc3d1x4
30 Jan 24
Prospectus supplement for primary offering
6:05am
8-K
EX-99.1
bm6uijbwrssx1kqa
22 Jan 24
Other Events
8:05am
DEFA14A
re1ybay kf8cob3a
2 Jan 24
Additional proxy soliciting materials
8:10am
DEFA14A
ph2pbf7l
22 Dec 23
Additional proxy soliciting materials
8:10am
8-K
EX-99.1
yk86hvitkldz74p
1 Dec 23
Seelos Therapeutics Announces Closing of Public Offering
4:08pm
8-K
EX-1.1
05s4c9bqb lu01am6
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-99.1
gj7bhgfsm8v2i0l2v
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
pfoy31c mcaxl29bz4
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
9nd9v 839qtpo7o
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
it7zp7j
28 Nov 23
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
w4yzsw af
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
12:07pm
8-K
EX-99.1
e02uyp 3z5iy2bd38fb
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
11:10am